WO2006050451A3 - Methodes et compositions pour traiter des maladies des motoneurones - Google Patents

Methodes et compositions pour traiter des maladies des motoneurones Download PDF

Info

Publication number
WO2006050451A3
WO2006050451A3 PCT/US2005/039710 US2005039710W WO2006050451A3 WO 2006050451 A3 WO2006050451 A3 WO 2006050451A3 US 2005039710 W US2005039710 W US 2005039710W WO 2006050451 A3 WO2006050451 A3 WO 2006050451A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
motor neuron
neuron disease
treat motor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/039710
Other languages
English (en)
Other versions
WO2006050451A2 (fr
Inventor
Brent R Stockwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Whitehead Institute for Biomedical Research
Original Assignee
Columbia University in the City of New York
Whitehead Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia University in the City of New York, Whitehead Institute for Biomedical Research filed Critical Columbia University in the City of New York
Publication of WO2006050451A2 publication Critical patent/WO2006050451A2/fr
Publication of WO2006050451A3 publication Critical patent/WO2006050451A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des compositions et des méthodes pour traiter des maladies des motoneurones, telles que l'amyotrophie spinale et la sclérose latérale amyotrophique. Ces compositions contiennent des dérivés d'indoprofène.
PCT/US2005/039710 2004-11-02 2005-11-02 Methodes et compositions pour traiter des maladies des motoneurones Ceased WO2006050451A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62422604P 2004-11-02 2004-11-02
US60/624,226 2004-11-02

Publications (2)

Publication Number Publication Date
WO2006050451A2 WO2006050451A2 (fr) 2006-05-11
WO2006050451A3 true WO2006050451A3 (fr) 2006-09-28

Family

ID=36319807

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/039710 Ceased WO2006050451A2 (fr) 2004-11-02 2005-11-02 Methodes et compositions pour traiter des maladies des motoneurones

Country Status (1)

Country Link
WO (1) WO2006050451A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8110681B2 (en) 2006-03-17 2012-02-07 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compounds for the treatment of spinal muscular atrophy and other uses
EP2215074B1 (fr) * 2007-09-27 2014-02-19 The United States of America, as Represented by the Secretary, Department of Health and Human Services Composés d'isoindoline pour le traitement d'une amyotrophie spinale et autres utilisations
US9212209B2 (en) * 2012-07-13 2015-12-15 Indiana University Research And Technology Corporation Screening methods for spinal muscular atrophy
KR102560706B1 (ko) 2015-10-01 2023-07-27 삼성전자주식회사 인도프로펜을 포함하는 조성물 및 그의 용도
JP6671664B2 (ja) * 2016-05-24 2020-03-25 学校法人東京女子医科大学 Ｓｍｎタンパク質の核内構造体の発現解析方法
AU2019272881A1 (en) * 2018-05-25 2020-12-10 Revalesio Corporation Inhibition of neurological disease
JP7486474B2 (ja) 2018-08-31 2024-05-17 レヴァレシオ・コーポレーション 脳卒中を治療する方法及び組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997669A (en) * 1972-12-26 1976-12-14 Ciba-Geigy Corporation Tertiary aminoacids
US4126691A (en) * 1968-03-27 1978-11-21 Ciba-Geigy Corporation Tertiary aminoacids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126691A (en) * 1968-03-27 1978-11-21 Ciba-Geigy Corporation Tertiary aminoacids
US3997669A (en) * 1972-12-26 1976-12-14 Ciba-Geigy Corporation Tertiary aminoacids

Also Published As

Publication number Publication date
WO2006050451A2 (fr) 2006-05-11

Similar Documents

Publication Publication Date Title
EP4585263A3 (fr) Thérapie génique pour troubles neurodégénératifs
WO2007022506A3 (fr) Méthodes et préparations pour le traitement d'une maladie neurologique
WO2008021210A3 (fr) Méthodes et compositions pour le traitement de troubles neurodégénératifs
WO2006083533A3 (fr) Compositions et methodes d'inhibition de la formation de drusen et methodes de diagnostic ou de traitement de pathologies liees aux drusen
WO2004100881A3 (fr) Preparation et utilisation de derives d'aryl alkyl acide pour le traitement de l'obesite
WO2004062625A3 (fr) Inhibiteurs de beta-secretase macrocyclique pour traiter la maladie d'alzheimer
WO2005004803A3 (fr) Inhibiteurs de la beta-secretase de phenylcarboxylate destines au traitement de la maladie d'alzheimer
WO2006001877A3 (fr) Composition pharmaceutique et methode de traitement de troubles neurodegeneratifs
WO2010048273A3 (fr) Procédés et composés pour le traitement de troubles neurodégénératifs
WO2007092622A3 (fr) Compositions et méthodes pour le traitement d'os
WO2006121560A3 (fr) Procedes et compositions pour le traitement des pathologies associees au systeme nerveux central
WO2006113864A3 (fr) Composes d'oxindole et leurs utilisations comme agents therapeutiques
WO2007137071A3 (fr) Compositions de r(+) et s(-) pramipéxole et procédés d'utilisation de celles-ci
WO2005018545A3 (fr) Inhibiteurs macrocycliques de la beta-secretase destines au traitement de la maladie d'alzheimer
WO2007016538A3 (fr) Preparation et utilisation de derives aminoacides biphenyle pour traiter l'obesite
WO2005051914A8 (fr) Inhibiteurs de benzylether et benzylamino de beta-secretase pour traiter la maladie d'alzheimer
WO2006058868A8 (fr) Pteridines substituees destinees au traitement de maladies inflammatoires
WO2007064932A3 (fr) Dérivés de pyrrolotriazine utiles pour traiter le cancer par inhibition de la kinase aurora
WO2005086656A3 (fr) Derives d'heteroarylaminopyrazole utilises pour traiter le diabete
WO2010075280A3 (fr) Composés à base de coumarine
WO2010041252A3 (fr) Utilisation d'un extrait d'écorce de cannelle dans le traitement de maladies associées à l'amyloïde
WO2006116609A8 (fr) Procedes permettant de traiter les maladies des neurones moteurs peripheriques et compositions associees
WO2006078576A3 (fr) Inhibiteurs de la $g(b)-secretase d'aminomethyle dans le traitement de la maladie d'alzheimer
WO2006057945A3 (fr) Derives pyridyle 2,3,4,6-substitues utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer
WO2004089369A3 (fr) Methodes et moyens permettant de traiter des troubles de conformation des proteines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05848830

Country of ref document: EP

Kind code of ref document: A2